Form 4: Hippo Holdings Officer Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Hippo Holdings Inc. GM & Chief Insurance, Michael Stienstra, sold 3,900 shares of common stock for approximately $31.12 per share under a pre-arranged trading plan.
Summary
- Michael Stienstra, the GM & Chief Insurance of Hippo Holdings Inc. (HIPO), reported a sale of common stock.
- The transaction involved the disposition of 3,900 shares of HIPO common stock.
- The shares were sold at a weighted average price of $31.1194 per share.
- The total value of the sale was approximately $121,365.66.
- The sale occurred on December 22, 2025.
- This transaction was executed pursuant to a Rule 10b5-1 trading plan established on September 21, 2025.
- Following the reported transaction, Michael Stienstra beneficially owns 71,281 shares of common stock, which includes 37,874 Restricted Stock Units (RSUs).
Sentiment
Score: 5
Explanation: An officer sold shares, which can be perceived as neutral to slightly negative, though the sale was pre-planned under a Rule 10b5-1 trading plan, mitigating concerns about opportunistic selling.
Positives
- The sale was conducted under a pre-arranged Rule 10b5-1 trading plan, indicating it was not based on new, non-public information and provides transparency.
Negatives
- An officer reduced their direct ownership in the company.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.
Industry Context
This filing reports a routine insider transaction and does not provide information related to broader industry trends or competitive landscape.
Stakeholder Impact
- Shareholders: A minor reduction in insider ownership, which is generally viewed as neutral given the pre-arranged nature of the 10b5-1 plan.
Key Dates
| Date | Description |
|---|---|
| 09/21/2025 | Date of Rule 10b5-1 trading plan establishment |
| 12/22/2025 | Date of the reported transaction (sale of common stock) |
| 12/24/2025 | Date the Form 4 was signed |
Keywords
HIPO, Hippo Holdings, insider trading, stock sale, Michael Stienstra, 10b5-1 plan, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.